Which US States Have the Highest Risk of Dementia?
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Your risk of developing dementia may be more closely tied to your ZIP code than you think, according to a large-scale study of U.S. military veterans aged 65 and older.
Analyzing health data from over 1.2 million veterans who received care through the Veterans Health Administration (VHA) between 1999 and 2021, researchers found that where someone lives can significantly influence their chances of developing dementia—even after accounting for age, race, heart disease, diabetes, and whether they lived in rural or urban areas.
The study revealed stark regional differences. Veterans living in the Southeast faced the highest risk, with dementia rates 25 percent higher than those living in the Mid-Atlantic, the region with the lowest rates.
Other high-risk areas included the Northwest and Rocky Mountains, where dementia risk was 23 percent higher than in the Mid-Atlantic. The South, Southwest and South Atlantic also showed elevated rates.
The researchers measured how many new cases of dementia were diagnosed each year per 1,000 people. In the Southeast, that number was 14 cases per 1,000 person-years, while in the Mid-Atlantic it dropped to just 11.2. Even after adjusting for factors like demographics, rurality and cardiovascular conditions, the regional patterns remained consistent.
"The study underscores the need to understand regional differences in dementia and the importance of region-specific prevention and intervention efforts," said senior author Dr. Kristine Yaffe, also of the San Francisco VA Health Care System, in a statement.
What Might Be Driving the Regional Differences?
Researchers explored why dementia rates varied so widely across regions, and several key factors may help explain the gap.
Although health, age, and environment clearly play a role, the data showed that geographic location remained a strong predictor even after accounting for those variables, suggesting there's more going on beneath the surface.
Potential Factors Influencing Dementia Risk:
Education: Lower educational attainment was more common in regions with higher dementia rates.
Health Conditions: Chronic illnesses such as stroke, high blood pressure, diabetes and obesity were more prevalent in higher-risk areas like the Southeast.
Lifestyle and Environment: Smoking and other regional lifestyle patterns may contribute.
Access and Quality of Health Care: While the VHA generally offers more equal care across regions, differences in resources and specialty care at individual VA centers may affect how—and whether—dementia is diagnosed.
Diagnosis Practices: Studies using Medicare data suggest that how often and how well dementia is diagnosed can vary, not just because of patient health but also due to how local health systems operate.
Hidden Variables: Some important influences—such as quality of early-life education or early signs of cognitive decline not captured in health records—may not show up in administrative data but could still drive long-term risk.
A stock image of a doctor visiting a senior man to check his health.
A stock image of a doctor visiting a senior man to check his health.
Photodjo/iStock / Getty Images Plus
All-in-all, the study makes one thing clear: location matters. While individual lifestyle choices and genetics remain important, where you live could shape your brain health more than previously understood.
These findings underscore the need for more localized research and targeted interventions, especially in regions facing higher dementia burdens.
Understanding why dementia hits harder in some areas than others is essential—not only for treating the disease but also for preventing it in the first place.
Do you have a tip on a health story that Newsweek should be covering? Do you have a question about dementia? Let us know via science@newsweek.com.
Reference
Dintica, C. S., Bahorik, A. L., Xia, F., Boscardin, J., & Yaffe, K. (2025). Regional differences in dementia incidence among US veterans. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2025.1536
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
30 minutes ago
- Wall Street Journal
Agency Overreach Leaves Patients Untreated
President Trump is pursuing deregulation to boost economic growth, but he could also use it to encourage medical innovation. As a first step, he could end the Coverage and Evidence Development program at the Centers for Medicare and Medicaid Services. CMS established the program two decades ago to speed Medicare coverage of new treatments that had been approved by the Food and Drug Administration. Instead, CED has slowed it down. In 2005 advances in medical devices were solving major medical problems, but CMS bureaucrats worried about taxpayer costs and demanded more data before covering them.
Newsweek
an hour ago
- Newsweek
Strawberry Moon 2025: Best Locations, Times to View Rare Full Moon Tonight
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Skywatchers across the United States will be treated to a rare lunar event: the annual "strawberry moon," set to peak later this week. While the name suggests a pink-hued moon, the term is historically tied to the strawberry harvest. This year's strawberry moon is significant due to a phenomenon known as a major lunar standstill, an event in the moon's 18.6-year cycle that occurs when the moon is at its northernmost or southernmost point, resulting from the gravitational pull of the sun. The full moon on June 11 will be as large and low in the sky as any full moon will appear until 2043, according to the Weather Channel. What Is a Strawberry Moon? The strawberry moon is the colloquial name for June's full moon, a term originating from Native American tribes who marked the time when wild strawberries reached peak ripeness. NASA notes that in the 1930s, the Maine Farmer's Almanac began publishing Native American names for full moons, like the "strawberry moon" for June. This name, associated with the time of year when strawberries are harvested in the northeastern United States, has since become widely recognized and used. Though its name conjures colorful imagery, the moon may not appear pink or red. However, atmospheric conditions near the horizon at moonrise or moonset may tint the moon with a subtle orange hue. The strawberry moon rises behind a tower at a marina in Cyprus on June 10, 2025. The strawberry moon rises behind a tower at a marina in Cyprus on June 10, 2025. AP Photo/Petros Karadjias When Is the Strawberry Moon? The strawberry moon will be visible on Tuesday night and Wednesday morning. When Is the Optimal Time to See the Strawberry Moon? The strawberry moon will rise in the southeast around dusk on Tuesday, June 10, and should be visible to most viewers. However, the moon will reach full illumination at 3:44 a.m. EST on Wednesday, June 11, and will be visible opposite the sunrise that morning. This year's strawberry moon is not just a typical lunar display but marks the most significant low-angle full moon viewers will see for nearly two decades. Where Is the Best Place to View the Strawberry Moon? The moon will be visible across the entire United States, but optimal viewing requires clear skies and minimal light pollution. Rural areas, high elevations, and open fields or waterfronts with a clear eastern view are ideal. Urban residents may want to seek local parks or other open areas to get the best vantage point. When Was the Last Strawberry Moon? The previous strawberry moon appeared on June 21, 2024. While similar in name and timing, the 2024 event did not coincide with the lunar standstill effect that makes the 2025 appearance visually unique. When Is the Next Full Moon? The next full moon after the strawberry moon will rise on July 13, 2025. Referred to as the "buck moon," it is named for the time of year when deer antlers are growing rapidly. Like its June predecessor, the July full moon will offer another opportunity for night sky observation, although it won't feature the same low-horizon prominence. With ideal weather and the rare lunar alignment, this week's strawberry moon provides a memorable stargazing opportunity that won't return in the same form until 2043.
Yahoo
an hour ago
- Yahoo
Global Healthy Living Foundation Peer-Reviewed Research Shows Hidden Risks of the Inflation Reduction Act's Drug Pricing Reform
Report reveals potential for higher patient costs, worse health outcomes despite lower "fair prices" UPPER NYACK, N.Y., June 10, 2025--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) has launched a research-backed public education campaign to raise awareness about the unintended consequences of drug pricing reforms under the Inflation Reduction Act (IRA). This initiative stems from a recent peer-reviewed paper co-authored by GHLF's Chief Science Policy Officer, Dr. Robert Popovian, Pharm.D., MS, published in the Journal of Health Economics and Outcomes Research (JHEOR). It includes a podcast episode, an infographic, and an article aimed at informing patients, caregivers, and policymakers. "The IRA's "maximum fair price" (MFP) policy was designed to reduce out-of-pocket costs for Medicare patients. However, it may lead to the opposite: higher out-of-pocket costs and increased health risks for vulnerable patients," report author Dr. Popovian says "By suppressing the retail price, CMS is reducing the profit margins and revenue for pharmacy benefit managers (PBMs), which is good. Predictably, the PBMs will not stand pat—they can shift the drug to a higher formulary tier, where patients will pay more out-of-pocket to acquire the medicine so the PBM can protect its profit margin," said Dr. Popovian in a recent episode of GHLF's Healthcare Matters podcast. The study specifically modeled outcomes for two widely used blood thinners, Eliquis and Xarelto. If PBMs reclassify these drugs to higher cost tiers to compensate for lost profit, patients could face an estimated $688 million more in out-of-pocket costs. This cost-shift could result in over 320,000 patients abandoning treatment, potentially leading to 145,000 major cardiovascular events and up to 97,000 deaths. "This research underscores a serious gap in how drug pricing reforms are being implemented and monitored," said Dr. Popovian. "Without proper oversight and transparency, policies that were meant to help patients could end up hurting them." The GHLF education campaign includes: A peer-reviewed paper published in JHEOR: "Could the Inflation Reduction Act Maximum Fair Price Hurt Patients?" A patient-friendly article: "Lower Prices, Higher Risk: How Drug Reform Could Backfire on Patients" published on GHLF's website and supported by social media A special podcast episode of Healthcare Matters, co-hosted by Dr. Popovian A downloadable infographic explaining the findings at-a-glance "This campaign is not about politics—it's about patients," said Seth Ginsberg, GHLF Co-Founder and President. "We want people to understand what's at stake when reforms don't account for the full complexity of our health care system." GHLF encourages policymakers, journalists, and patient advocates to explore these resources and consider how reforms like the IRA impact access to critical medications. About GHLF The Global Healthy Living Foundation is a U.S. based, 501(c)(3) nonprofit, international organization whose mission is to improve the quality of life for people with chronic illnesses by advocating for improved access to health care through education, patient-centered clinical research, support, advocacy, and economic and policy research. GHLF is also a staunch advocate for vaccines. The Global Healthy Living Foundation is the parent organization of CreakyJoints®, the international, digital community for millions of people living with arthritis and their supporters worldwide who seek education, support, activism, and patient-centered research in English, Spanish, and French. In addition to arthritis and autoimmune disorders, GHLF supports dermatology, gastroenterology, neurology, cardiology, oncology, infectious disease, rare disease, and pulmonary patients through a host of different programs and activities which draw more than 700,000 patients a month to GHLF websites and create more than 10 million impressions a month on seven social media platforms. In 2024, GHLF had more than 1 million views and listens with its patient-centered audio-visual content, found on YouTube and podcast platforms. GHLF never asks the public for donations, receiving funding instead through governments, non-governmental organizations, foundations, industry, family foundations, and GHLF Co-Founder Louis Tharp. Visit for more information. View source version on Contacts Louis Tharpltharp@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
